Pilot Study on Evaluating the Geroprotective Effect of Metformin
NCT06459310
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
130
Enrollment
OTHER
Sponsor class
Conditions
Metformin
Aging
Interventions
DRUG:
Metformin Hydrochloride tablet
DRUG:
Placebo
Sponsor
Xuanwu Hospital, Beijing
Collaborators
[object Object]
[object Object]
[object Object]